Summit Therapeutics Inc.

NasdaqGM:SMMT Stok Raporu

Piyasa değeri: US$14.7b

Summit Therapeutics Yönetim

Yönetim kriter kontrolleri 2/4

Summit Therapeutics CEO'su Bob Duggan, Jul2022 tarihinde atandı, in görev süresi 2.33 yıldır. şirketin hisselerinin 74.81% doğrudan sahiptir ve bu hisselerin değeri $ 11.03B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 4.5 yıldır.

Anahtar bilgiler

Bob Duggan

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi2.3yrs
CEO sahipliği74.8%
Yönetim ortalama görev süresi2.3yrs
Yönetim Kurulu ortalama görev süresi4.5yrs

Son yönetim güncellemeleri

Recent updates

Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry?

Nov 08
Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry?

Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market

Oct 04

Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial

Sep 19

Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)

Sep 09

Summit Therapeutics May Have Further Upside From Here

Aug 03

Summit Therapeutics Stock: Plunging Despite A Win?

May 31

Summit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer

May 06

Summit Therapeutics: A Strategic Analysis Of Ivonescimab's Progress

Jan 30

We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely

Dec 29
We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely

Summit Therapeutics slips on plans to terminate study for lead candidate

Oct 04

Summit Therapeutics: Developing Antibiotics Is A Noble Cause But The Company Is Wise To Expand Its Portfolio

Aug 17

Summit Therapeutics GAAP EPS of -$0.17, revenue of $0.23M

Aug 11

Summit to explore additional trial for its bacteria-induced colon infection drug

Jul 14

Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation

Apr 29
Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation

Summit Therapeutics - Disappointing Data But Not An Outright Failure

Dec 23

Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator

Jun 22

Summit Therapeutics to join Russell 3000 Index

Jun 08

CEO

Bob Duggan (80 yo)

2.3yrs

Görev süresi

Mr. Robert W. Duggan, also known as Bob, had been an Interim Principal Financial Officer at Summit Therapeutics Inc. since July 02, 2021. He served as the Co-Chief Executive Officer at Summit Therapeutics...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Robert Duggan
Co-CEO & Executive Chairman2.3yrsVeri yok74.81%
$ 11.0b
Mahkam Zanganeh
Co-CEO, President & Director2.3yrsUS$20.56m4.85%
$ 714.8m
Manmeet Soni
COO, CFO & Director1.1yrsUS$23.97m0.41%
$ 60.4m
Dame Davies
Co-Founderno dataVeri yokVeri yok
Bhaskar Anand
Chief Accounting Officer & Head of Financeless than a yearVeri yok0.018%
$ 2.6m
Abby Murphy
Head of Human Resources1.6yrsVeri yokVeri yok
Divya Chari
Head of Global Clinical Operations4.7yrsVeri yokVeri yok
Dave Gancarz
Chief Business & Strategy Officerno dataVeri yokVeri yok
Betty Chang
Head of Research3.4yrsVeri yokVeri yok
Fong Clow
Chief Biometrics Officer3.8yrsVeri yokVeri yok
Shelley Spray
Chief Education & Brand Officer1.8yrsVeri yokVeri yok
Juthamas Sukbuntherng
Head of Clinical Pharmacology & DMPK3.3yrsVeri yokVeri yok

2.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: SMMT 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Robert Duggan
Co-CEO & Executive Chairman4.9yrsVeri yok74.81%
$ 11.0b
Mahkam Zanganeh
Co-CEO, President & Director4yrsUS$20.56m4.85%
$ 714.8m
Manmeet Soni
COO, CFO & Director4.9yrsUS$23.97m0.41%
$ 60.4m
Dame Davies
Co-Founderno dataVeri yokVeri yok
Kenneth Clark
Lead Independent Director3.1yrsUS$334.65kVeri yok
Marcel van den Heuvel
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Francesco Muntoni
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Roger Patient
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Edith Sim
Member of Scientific Advisory boardno dataVeri yokVeri yok
Bob Sim
Member of Scientific Advisory boardno dataVeri yokVeri yok
Derek Stemple
Member of Scientific Advisory boardno dataVeri yokVeri yok
Jean-Paul Vincent
Member of Scientific Advisory boardno dataVeri yokVeri yok

4.5yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SMMT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.5 yıldır).